Rising Rate of Drug Shortages Is Framed as a National Security Threatnews2023-03-22T20:54:10+00:00March 22nd, 2023|The New York Times|
F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatmentnews2023-03-16T21:15:49+00:00March 16th, 2023|The New York Times|
What to Know About the Recent Eye Drop Recallsnews2023-03-16T16:50:11+00:00March 16th, 2023|The New York Times|
Judge in Abortion Pill Case Set Hearing but Sought to Delay Telling the Publicnews2023-03-12T22:39:02+00:00March 12th, 2023|The New York Times|
¿Podría el próximo fármaco de éxito conseguirse sin ratas de laboratorio?news2023-03-12T10:00:10+00:00March 12th, 2023|The New York Times|
F.D.A. Approves New Nasal Spray for Migrainesnews2023-03-10T18:37:27+00:00March 10th, 2023|The New York Times|
Walgreens Faces Blowback for Not Offering Abortion Pill in 21 Statesnews2023-03-08T02:48:07+00:00March 8th, 2023|The New York Times|
Preterm Birth Drug Withdrawn After 12 Yearsnews2023-03-08T01:17:50+00:00March 8th, 2023|The New York Times|
Could the Next Blockbuster Drug Be Lab-Rat Free?news2023-03-07T08:00:08+00:00March 7th, 2023|The New York Times|
FDA Panel Recommends 2 RSV Vaccines for Older Adultsnews2023-03-01T21:29:15+00:00March 1st, 2023|The New York Times|
